FDA of­fers more guid­ance on de­vel­op­ing cell and gene ther­a­pies

6 months ago
Cell/Gene Tx
FDA+

Re­genxbio shares first da­ta show­ing Duchenne gene ther­a­py im­proves mus­cle func­tion

6 months ago
R&D

A rare neu­ro­log­i­cal dis­ease is Sage’s last, best hope af­ter fail­ures in de­pres­sion

6 months ago
R&D
Pharma

As car­diomy­opa­thy mar­ket ex­pands, Al­ny­lam of­fers look at Phase 1 da­ta in healthy vol­un­teers

6 months ago
R&D

Aclaris makes a deal, aims to raise $80M; Em­me­cell’s Ph1 up­date in corneal ede­ma

6 months ago
News Briefing

At­las Ven­ture tar­gets $450M for 14th biotech fund, the same size as its 2022 raise

6 months ago
Financing
Startups

No­var­tis strikes ra­dio­phar­ma deal with Ra­tio worth up to $745M

6 months ago
Startups
Deals

Cy­bin says its psy­che­del­ic drug can sus­tain re­mis­sion in de­pres­sion pa­tients

6 months ago
R&D

Ex­clu­sive: Athena Coun­tou­ri­o­tis' Aven­zo taps Shang­hai biotech for ADC, adds new funds

6 months ago
Startups
Deals

In­tel­lia touts first clin­i­cal out­comes on CRISPR-based AT­TR amy­loi­do­sis as­set

6 months ago
R&D
Cell/Gene Tx

Scot­tish biotech de­buts with ‘Tro­jan horse’ plat­form for can­cer

6 months ago
Startups
R&D

Ei­sai ter­mi­nates Phase 3 tri­al of Dravet drug, cit­ing re­cruit­ment chal­lenges

6 months ago
R&D
Pharma

Trump picks RFK Jr. for HHS; Ab­b­Vie's psych im­plo­sion; Mer­ck tries staving off Sum­mit; and more

6 months ago
Weekly

Il­lu­mi­na seeks to dis­miss share­hold­er law­suit, de­nies se­cret $800M stake

6 months ago
Diagnostics
Law

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

6 months ago
Editor's note
FDA+

Eu­ro­pean drug reg­u­la­tors of­fer wave of pos­i­tive rec­om­men­da­tions fol­low­ing Leqem­bi re­ver­sal

6 months ago
Pharma

Eye­n­ovia halts Phase 3 my­opia tri­al, to con­sid­er sell­ing as­sets

6 months ago
R&D

Boston Phar­ma­ceu­ti­cals hits Phase 2 goals as it tries to keep up with MASH com­peti­tors

6 months ago
R&D

Vi­tal­li ends work on Dae­woong as­set; Alec­tor’s $50M loan

6 months ago
News Briefing

Evotec gains on Halozyme's takeover pro­pos­al

6 months ago
Deals
Manufacturing

ALX On­col­o­gy hires Genen­tech, Mi­rati vet as CMO; Af­ter Car­mot, Heather Turn­er has three new roles on tap

6 months ago
Peer Review

Adap­ti­m­mune to 're­de­fine' it­self as a sar­co­ma biotech, cuts a third of staffers

6 months ago
People
R&D

Eli Lil­ly sues the US gov­ern­ment over its pro­posed 340B re­bate mod­el

6 months ago
Pharma
FDA+

Trump picks vac­cine skep­tic Kennedy to lead HHS, in what would be an up­heaval of US health pol­i­cy

6 months ago
People
Pharma
First page Previous page 75767778798081 Next page Last page
A service from the Financial Times